The global Clinical Microbiology Market is witnessing steady growth, driven by factors such as the rise in infectious diseases, government subsidization of healthcare, and increasing research funding.

A recent blood-based hepatitis C virus assay on Nuclein's DASH system highlighted its on-device sample prep, among other features that have been driving its adoption.

Cancer’s cruelest trick is its ability to disappear, only to reappear years later in a new organ or a familiar scar. The fear ...

San Diego County health officials have launched a new tool to monitor the spread of disease by testing local wastewater for ...

The ROAR trial tested the hypothesis that returning familial hypercholesterolemia-associated genetic results leads to ...

Rapid and reliable virus detection is one of the most critical tools for controlling outbreaks, from seasonal influenza to ...

Hoping to catch serious illnesses early, more Americans are ordering lab tests online, but their doctors don't know what to ...

The data illustrate that several patients remained on zenocutuzumab well beyond progression, including multiple patients who continued treatment for more than one- or two-years post-progression.

Experts explore HER2 mutations and the critical role of comprehensive molecular profiling in optimizing treatment for ...

A new database targeting chronic urinary tract infections (UTIs)—a long-overlooked condition that may begin in childhood—is set to help researchers uncover why millions of women and girls worldwide ...

A study based on Finnish twins shows that reproductive history is associated, at the population level, with women's lifespan and biological aging. In the study, mothers of large families, women who ...

MISSISSAUGA, ON / ACCESS Newswire / January 9, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF) (Microbix), a life sciences ...